← Eichor
Study identifier: NCT06162767 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis

Condition: Esophagogastric Junction Carcinoma  ·  Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

PhaseNA
Planned participants240
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This study is being done to see whether Optimized Sweet Procedure is superior than the Ivor-Lewis Procedure Esophagectomy with better long-term outcome and acceptable postoperative short-term outcome or not.

This description comes directly from the study's public registry record.

Talk to the study team

Louqian Zhang, MD  ·  +86-02556682004  ·  zhanglouqian@njmu.edu.cn

Rulin Zhuang, MD, PhD  ·  +86-02556682004  ·  Rulinzhuang@njmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06162767